Prescription pattern of fixed dose drug combinations in obstetrics and gynecology department of a tertiary care hospital in Puducherry, India: an observational study

Authors

  • Manjunatha C. H. Department of Pharmacology, Pondicherry Institute of Medical Sciences, Pondicherry, India
  • Rohith V. Department of Pharmacology, Pondicherry Institute of Medical Sciences, Pondicherry, India
  • Maheshwari R. Department of Pharmacology, Pondicherry Institute of Medical Sciences, Pondicherry, India
  • Isabella Topno Department of Pharmacology, Pondicherry Institute of Medical Sciences, Pondicherry, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20184311

Keywords:

Fixed drug combinations, Prescription, irrational, ATC classification

Abstract

Background: Fixed drug combinations (FDCs)have various advantages and disadvantages. In countries like India there are numerous irrational prescriptions as highlighted by the recent banning of FDCs in October 2018. Studying the prescription pattern helps in developing national database which can be used to promote rational use of drugs.

Methods: All the Outdoor Patient Department (OPD) prescriptions from department of Obstetrics and Gynecology (OBG) during the study period were used for the study. The drugs were classified according to Anatomical Therapeutic Chemical (ATC) classification. Other data studied were the number of FDCs and the number of currently banned combinations which were used during the study period.

Results: The 41% of the drugs prescribed as FDCs. Most FDCs belonged to alimentary system followed by anti-infectives and blood and blood forming organs group. Vitamin D3 and Calcium combination was the most commonly prescribed FDC. Approximately 20% of these prescribed drugs are currently banned.

Conclusions: A significant number of drugs are being prescribed as FDCs which also includes various irrational combinations.

References

WHO Expert Committee on Specifications for Pharmaceutical Preparations: thirty-ninth report. (WHO technical report series; 929); 2005.

World Health Organization. Regulation of fixed-dose combination products. WHO Drug Information. 2003;17(3). Available at: http://apps.who.int/medicinedocs/en/d/Js4955e/7.html accessed on 14 September 2018

Gautam CS, Saha L. Fixed dose drug combinations (FDCs): rational or irrational: a view point. Bri J Clinical Pharmacol. 2018;65(5):795-6.

DD news. Gove bans 328 fixed dose combination drugs with immediate effect. Available at: http://ddnews.gov.in/health/govt-bans-328-fixed-dose-combination-drugs-immediate-effect accessed on 15/09/2018

Jain S, Upadhyaya P, Goyal J, Kumar A, Jain P, Seth V, et al. A systematic review of prescription pattern monitoring studies and their effectiveness in promoting rational use of medicines. Perspectives in Clinical Research. 2015;6(2):86-90.

Gupta YK, Ramachandran SS. Fixed dose drug combinations: Issues and challenges in India. Indian J Pharmacol. 2016;48:347-9.

Eesha BR, Shanbhag T, Adiga MNS, Shenoy S. Prescription Pattern of Fixed Dose Drug Combination in Tertiary Care Hospital: An Evaluation Study. Biomedical Research. 2009;20(3):176-9.

Das B, Sarkar C, Datta A, Bohra S. A study of drug use during pregnancy in a teaching hospital in western Nepal. Pharmacoepidemiol Drug Saf. 2003;12(3):221-5.

Upadhyay D, Singh A, Joshi H, Agarwal M, Katyal R. Study of Prescription Patterns of Fixed Dose Combinations Prescribed by Medical Interns. IJBR 2016;7(9):624-8.

The gazette of India. Available at: http://egazette.nic.in/(S(03j4qcdv53fnnkbtre4tpsyq))/EnhancedSearch.aspx. Accessed 16 October 2018.

Downloads

Published

2018-10-23

How to Cite

C. H., M., V., R., R., M., & Topno, I. (2018). Prescription pattern of fixed dose drug combinations in obstetrics and gynecology department of a tertiary care hospital in Puducherry, India: an observational study. International Journal of Basic & Clinical Pharmacology, 7(11), 2122–2125. https://doi.org/10.18203/2319-2003.ijbcp20184311

Issue

Section

Original Research Articles